University of Bordeaux
Also known as: Bordeaux 2 University, France | Bordeaux (FR), Pellegrin Regional Hospital | Bordeaux, Pellegrin Regional Hospital | Bordeaux Population Health Research Center (Inserm U1219) | Bordeaux University | Bordeaux University Hospital | CHU Bordeaux | CHU - Bordeaux | CHU BORDEAUX | CHU Bordeaux, France | CHU de Bordeaux, F-33000 | CHU de Bordeaux, Groupe Hospitalier Pellegrin | CHU de Bordeaux & INSERM, Université de Bordeaux, France | CIC-EC7 - ISPED - CHU de Bodeaux | CIC-EC7 - ISPED - CHU de Bordeaux | Clinic Saint-Augustin, Bordeaux, France | Clinique Bordeaux Nord | Clinique Bordeaux Nord, Bordeaux, France | DAR 3 -Pellegrin hospital-33076 Bordeaux - France | Hopital Bordeaux | Hopital de Bordeaux | HOPITAL DE HAUT LEVEQUE - PESSAC CEDEX | Hopital du Haut-Leveque, Service d'Hepato-Gastroenterologie, Pessac 33604, France | Hopital Haut Leveque | Hôpital Haut-Lévêque | HOPITAL ST ANDRE - BORDEAUX CEDEX | Hospital Pellegrin, Bordeaux, France | INCIA - Unité CNRS UMR5287_University of Bordeaux | Inserm 1219 | Inserm 1219, Université de Bordeaux, France | Inserm U1219 Bordeaux Population Health Center | Inserm U1219 Bordeaux Population Health Center, University of Bordeaux | Institut Bergonié - University of Bordeaux 2 | Laboratory of Nutrition And Integrative Neurbiology INRA - Bordeaux University | Pellegrin hospital | Polyclinique Bordeaux Nord Aquitaine-BORDEAUX | Polyclinique de Bordeaux Nord | Polyclinique de BORDEAUX NORD France | UH Bordeaux | Unité CNRS UMR5296, Groupe d'Imagerie | Univ Bordeaux France | Universitary Hospital Pellegrin | Université de Bordeaux | Université Victor Segalen Bordeaux 2 | University hospital - 33076 Bordeaux - France | University Hospital, Bordeaux | university hospital, Bordeaux, France | University Hospital Bordeaux (France) | University Hospital Bordeaux, France | University Hospital, Bordeaux France | University Hospital, Bordeaux, France | University Hospital Bordeaux (Pellegrin Hospital), Bordeaux 33076, France | University Hospital, Bordeaux, USMR | University of Bordeaux | University of Bordeaux, INSERM, Bordeaux Population Health | Universty Hospital, Bordeaux | Univestity Hospital, Bordeaux | USMR | USMR Bordeaux | USMR, CHU de Bordeaux | USMR (University Hospital, Bordeaux)
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2001Last known activity
Jul 5, 2025
Timeline
1440s
- Jan 1, 1441
University of Bordeaux— Founded
Drugs by trial phase (216 distinct, 175 trials)
Phase 4 (26 own, 0 via acquisition)
Phase 3 (92 own, 0 via acquisition)
Phase 2 (46 own, 0 via acquisition)
Phase 1 (7 own, 0 via acquisition)
Other trials (45 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Acute Kidney Injury
- Adamantinoma
- Adenocarcinoma
- Alzheimer Disease
- Anemia
- Anemia, Hemolytic
- Anemia, Hemolytic, Autoimmune
- Angiomyolipoma
- Anxiety Disorders
- Aortic Valve Stenosis
- Arthritis
- Arthritis, Rheumatoid
- Asthma
- Astrocytoma
- Atrial Fibrillation
- Atrophy
- Autonomic Nervous System Diseases
- Back Pain
- Basal Cell Carcinoma
- Brain Infarction
- Brain Injuries
- Brain Injuries, Traumatic
- Brain Ischemia
- Breast Neoplasms
- Brugada Syndrome
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Cardiomyopathies
- Cardiomyopathy, Hypertrophic
- Cerebral Hemorrhage
- Cerebral Infarction
- Chlamydia Infections
- Chronic Disease
- Chronic Pain
- Colorectal Neoplasms
- Communicable Diseases
- Coronavirus Infections
- Craniofacial Abnormalities
- Craniopharyngioma
- Cystic Fibrosis
- Cytomegalovirus Infections
- Dental Plaque
- Disease Progression
- Emergencies
- Epistaxis
- Esophageal Neoplasms
- Fatigue
- Fibrosis
- Glioblastoma
- Glioma
- Graft vs Host Disease
- Hand Deformities, Congenital
- Hemangioma
- Hemangioma, Capillary
- Hemolysis
- Hemorrhage
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hepatitis C, Chronic
- HIV Infections
- Hyperalgesia
- Hypercholesterolemia
- Hyperplasia
- Hypertension
- Hypertension, Pulmonary
- Hypertrophy
- Hypoxia, Brain
- Immune System Diseases
- Infarction
- Infections
- Inflammation
- Invasive Fungal Infections
- Ischemia
- Kidney Diseases
- Kidney Failure, Chronic
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Low Back Pain
- Lung Diseases, Obstructive
- Lung Neoplasms
- Lupus Erythematosus, Systemic
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Malaria
- Medulloblastoma
- Melanoma
- Meningitis
- Monoclonal Gammopathy of Undetermined Significance
- Multiple Myeloma
- Multiple Sclerosis
Recent trials (50)
- NCT07013240OfficialPhase 3Jul 5, 2025
- NCT07013240Lead sponsorPhase 3Jul 5, 2025
- NCT06892951CollaboratorPhase 1/Phase 2Jun 30, 2025
- NCT06585020CollaboratorPhase 2Oct 31, 2024
- NCT06449339CollaboratorPhase 4Jul 17, 2024
- NCT06212336CollaboratorPhase 2/Phase 3Jul 1, 2024
- NCT05674487Lead sponsorN/AMar 1, 2024
- NCT06059144Lead sponsorPhase 3Jan 1, 2024
- NCT06059144Study chairPhase 3Jan 1, 2024
- NCT05917561Lead sponsorPhase 2Dec 15, 2023
- NCT06024421OfficialPhase 1Nov 30, 2023
- NCT05946486Lead sponsorPhase 3Oct 15, 2023
- NCT05946486Overall official - principal investigatorPhase 3Oct 15, 2023
- NCT06234813OfficialN/AApr 6, 2023
- NCT06234813Lead sponsorN/AApr 6, 2023
Details
- Founded
- Bordeaux, FR Jan 1, 1441
- Last known activity
- Jul 5, 2025